Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/222700
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Age distribution of multiple functionally relevant subsets of CD4+ T cells in human blood using a standardized and validated 14-color EuroFlow immune monitoring tube

AuthorsBotafogo, Vitor; Pérez-Andrés, Martin; Jara-Acevedo, Maria; Bárcena, Paloma; Grigore, Georgiana Emilia; Hernández-Delgado, Alejandro; Damasceno, Daniela; Comans, Suzanne; Blanco, Elena; Romero, Alfonso; Arriba-Méndez, Sonia; Gastaca, Irene; Pedreira, C. E.; Gaans-van den Brink, Jacqueline A. M. van; Corbiere, Véronique; Mascart, Françoise; Els, Cécile A. C. M. van; Barkoff, Alex-Mikael; Mayado, Andrea; Dongen, J. J. M. van; Almeida, Julia CSIC ORCID; Orfao, Alberto CSIC ORCID
Issue Date2020
PublisherFrontiers Media
CitationFrontiers in Immunology 11: 166 (2020)
AbstractCD4+ T cells comprise multiple functionally distinct cell populations that play a key role in immunity. Despite blood monitoring of CD4+ T-cell subsets is of potential clinical utility, no standardized and validated approaches have been proposed so far. The aim of this study was to design and validate a single 14-color antibody combination for sensitive and reproducible flow cytometry monitoring of CD4+ T-cell populations in human blood to establish normal age-related reference values and evaluate the presence of potentially altered profiles in three distinct disease models—monoclonal B-cell lymphocytosis (MBL), systemic mastocytosis (SM), and common variable immunodeficiency (CVID). Overall, 145 blood samples from healthy donors were used to design and validate a 14-color antibody combination based on extensive reagent testing in multiple cycles of design–testing–evaluation–redesign, combined with in vitro functional studies, gene expression profiling, and multicentric evaluation of manual vs. automated gating. Fifteen cord blood and 98 blood samples from healthy donors (aged 0–89 years) were used to establish reference values, and another 25 blood samples were evaluated for detecting potentially altered CD4 T-cell subset profiles in MBL (n = 8), SM (n = 7), and CVID (n = 10). The 14-color tube can identify ≥89 different CD4+ T-cell populations in blood, as validated with high multicenter reproducibility, particularly when software-guided automated (vs. manual expert-based) gating was used. Furthermore, age-related reference values were established, which reflect different kinetics for distinct subsets: progressive increase of naïve T cells, T-helper (Th)1, Th17, follicular helper T (TFH) cells, and regulatory T cells (Tregs) from birth until 2 years, followed by a decrease of naïve T cells, Th2, and Tregs in older children and a subsequent increase in multiple Th-cell subsets toward late adulthood. Altered and unique CD4+ T-cell subset profiles were detected in two of the three disease models evaluated (SM and CVID). In summary, the EuroFlow immune monitoring TCD4 tube allows fast, automated, and reproducible identification of ≥89 subsets of CD4+ blood T cells, with different kinetics throughout life. These results set the basis for in-depth T-cell monitoring in different disease and therapeutic conditions.
DescriptionOn behalf of the EuroFlow and PERISCOPE consortia.
Publisher version (URL)https://doi.org/10.3389/fimmu.2020.00166
URIhttp://hdl.handle.net/10261/222700
DOI10.3389/fimmu.2020.00166
E-ISSN1664-3224
Appears in Collections:(IBMCC) Artículos

Files in This Item:
File Description SizeFormat
agemonitor.pdf4,64 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

PubMed Central
Citations

12
checked on May 16, 2022

SCOPUSTM   
Citations

14
checked on May 11, 2022

WEB OF SCIENCETM
Citations

12
checked on May 13, 2022

Page view(s)

105
checked on May 17, 2022

Download(s)

113
checked on May 17, 2022

Google ScholarTM

Check

Altmetric

Dimensions


Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.